Buscar
Mostrando ítems 1-10 de 30
Varenicline and cytisine: two nicotinic acetylcholine receptor ligands reduce ethanol intake in University of Chile bibulous rats
(Springer, 2013)
Rationale Neuronal nicotinic acetylcholine receptors (nAChRs)
are pharmacological targets that have recently been implicated in
the reinforcing effects ofmany drugs of abuse, including ethanol.
Varenicline and cytisine ...
Effects of Varenicline in Adult Smokers: A Multinational, 24-Week, Randomized, Double-Blind, Placebo-Controlled Study
(ELSEVIER, 2011)
Background: Prevalence rates of smoking are rising in developing countries. Previous trials evaluating the efficacy and tolerability of the smoking-cessation medication varenicline have used largely participants of Caucasian ...
Guías de Práctica Clínica para el Tratamiento del Tabaquismo, Chile 2017
(Sociedad Médica Santiago, 2017)
Considering that a high proportion of the Chilean general population smokes, the Chilean Society of Respiratory Diseases in collaboration with the Chilean Societies of Cardiology and, Endocrinology and Diabetes, formed an ...
Clinical Practice Guidelines for Smoking Cessation
(SOC MEDICA SANTIAGO, 2017)
Considering that a high proportion of the Chilean general population smokes, the Chilean Society of Respiratory Diseases in collaboration with the Chilean Societies of Cardiology and, Endocrinology and Diabetes, formed an ...
Factors associated with success of a smoking cessation program Factores asociados con el éxito de la terapia antitabaco en pacientes tratados con vareniclina: 10 años de experiencia en un programa multidisciplinario
(Sociedad Medica de Santiago, 2016)
© 2016, Sociedad Medica de Santiago. All right reserved. Background: Smoking cessation therapies include counseling, psychological management and pharmacological therapy. Varenicline is the most effective and safe medication ...
Vareniclina; una ayuda para dejar de fumar
(2007-06-01)
La vareniclina es un medicamento aprobado por la FDA en mayo de 2006 para ayudar a las personas que quieren dejar de fumar. La vareniclina es un agonista parcial de los receptores cerebrales nicotínicos α4β2, asociados a ...
Vareniclina; una ayuda para dejar de fumar
(2007-06-01)
La vareniclina es un medicamento aprobado por la FDA en mayo de 2006 para ayudar a las personas que quieren dejar de fumar. La vareniclina es un agonista parcial de los receptores cerebrales nicotínicos α4β2, asociados a ...